arrow
J

Jean-François Dufour

University Hospital of Bern
H指数:82
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma

肝病学:MASLD、病毒性肝炎、胆汁淤积性肝病、门静脉高压和肝细胞癌的新兴范式

2026-08-300
PRE
Health-care burden of metabolic dysfunction-associated steatotic liver disease in European tertiary-care outpatient clinics (CONSTANS): a prospective multicentre cohort study

欧洲三级保健门诊中代谢功能障碍相关脂肪性肝病的医疗负担(CONSTANS):一项前瞻性多中心队列研究

2026-01-010
OA
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD
2025-01-241
OAAI
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
2024-11-211
PRE
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

基于与人类代谢功能障碍相关的脂肪变性肝病 (MASLD) 的接近程度,对小鼠饮食模型进行无偏排名

2024-06-1233
OA
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma
2024-01-012
OA
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis
2023-11-0136
OAAI
Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients
2023-11-018
PRE
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

非酒精性脂肪肝疾病中纤维化和非酒精性脂肪性肝炎分期的生物标志物 (石蕊项目): 一项比较诊断准确性研究

2023-08-0165
OAAI
Genome-wide association study of non- alcoholic fatty liver and steatohepatitis in a histologically characterised cohort( vol 73, pp 505-515 , 2020 )
2023-05-012
OA
Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich syndrome): Frequency, clinical implication, and prognosis
2023-05-0110
PREAI
NAFLD and NASH biomarker qualification in the LITMUS consortium-Lessons learned

石蕊联盟中的NAFLD和NASH生物标志物资格-经验教训

2023-04-0120
OAAI